Investing is the act of putting money into a venture with the expectation of earning a return on that investment. There are many different types of investments, including stocks, bonds, real estate, and small businesses.
Many people buy and sell stocks (i.e. dividends), which are shares of ownership in a company. When you buy stocks, you become a shareholder in that company. If the company does well, the value of your stocks will go up. Also, if the company pays a dividend, then you get cash to use for whatever you want. And if the company does poorly, the value of your stocks will go down.
Options are another type of investment. With options, you don’t actually own any shares of the underlying stock. Instead, you’re buying the right to buy or sell shares at a certain price.
Investing in real estate is a often a slow process. It can take years to see a return on your investment, but it can be a very lucrative one. Real estate investing involves the purchase, ownership, management, and sale of real property for profit.
There are many different ways to make money in real estate. You can buy properties and then sell them for a profit. You can buy properties and rent them out. You can also trade real estate investment trusts (REITs), which are companies that own, operate, or finance income-producing real estate.
Investing in a small business is another way to earn a return on your investment. Small businesses are often more volatile than larger businesses, but they can also offer a higher return.
Investing can be a great way to make money, but it’s not without risk. Before you invest, it’s important to do your research and understand the potential risks and rewards.
Tempus AI (NASDAQ:TEM) sits at the intersection of artificial intelligence, genomics, oncology, and drug development. That combination has created a compelling growth story, especially as the company expands artificial intelligence tools and biopharma partnerships. The stock’s challenge is simple: growth is impressive, but Wall Street still needs proof that the model can scale profitably. Stock … Read more
Micron (NASDAQ:MU) is riding one of the market’s most exciting AI memory stories, but its Virginia expansion points to a broader opportunity. The company isn’t just chasing data center demand. It’s also targeting industries that need reliable long-term memory supply, including defense, automotive, aerospace, industrial equipment, and medical devices. Stock prices used were the market … Read more
Advanced Micro Devices (NASDAQ:AMD) may be entering the most important phase of its AI story. Training grabbed the early spotlight, but inference could drive continuous demand across data centers. That creates a powerful setup for AMD, though the valuation now leaves little room for disappointment. Stock prices used were the market prices of May 29, … Read more
Marvell (NASDAQ:MRVL) has become a serious artificial intelligence infrastructure story as custom silicon, optical networking, and data center demand reshape its growth profile. The stock’s rally reflects rising confidence that hyperscalers need more efficient alternatives to general-purpose graphics processing units, but the valuation now forces investors to ask whether the upside still outweighs the risk. … Read more
Applied Digital (NASDAQ:APLD) has become one of the market’s most dramatic AI infrastructure stories after a massive rally and a new hyperscaler lease. The bullish thesis is simple but powerful: long-term contracted demand, scarce AI data center capacity, and a backlog that could support years of growth. The harder question is whether investors are already … Read more
Poet Technologies (NASDAQ:POET) is trying to move beyond its development-stage reputation and prove that its optical technology can serve the next wave of AI data centers. The Lumilens order has revived the bull case, but investors still have to weigh weak current revenue, dilution, and the pressure to scale production. Stock prices used were the … Read more
Meta (NASDAQ:META) faces one of the clearest investor dilemmas in big tech. The CapEx numbers look intimidating, but the company isn’t chasing AI without a business model. It’s embedding AI directly into advertising, where the money already flows and where even small improvements can create meaningful upside. Stock prices used were the market prices of … Read more
Hims & Hers Health (NYSE:HIMS) is facing one of the most important moments in its growth story. The stock has fallen sharply, margins are under pressure, and investors are questioning whether GLP-1 demand can become a durable profit engine. But subscriber growth, positive cash flow, and international expansion still leave room for a much bigger … Read more
SpaceX (NASDAQ:SPCX) is not just entering the public market as a rocket company. It is arriving with Starlink, Starship, AI infrastructure, defense exposure, and one of the most ambitious growth stories investors have seen in years. The bullish case is powerful, but the spending risk could force investors to separate excitement from actual returns. Stock … Read more
IonQ (NYSE:IONQ) is emerging as the clearest execution story in a quantum computing sector still filled with hype, losses, and uncertainty. D-Wave (NYSE: QBTS) has a compelling enterprise angle, while Rigetti (NASDAQ: RGTI) offers high-risk upside, but IonQ’s revenue growth and government relationships make this comparison much harder to ignore. Stock prices used were the … Read more
You Found Me :)
Now Let's Grow Your Wealth
Learn to invest like the pros—even if you're just starting.
